$BNR Cashflow Statement | Understand Stock

$BNR

$11.87 +$0.72 (6.46%) Close

$BNR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements Of Cash Flows

In millions of CNY, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net Income Loss
Adjustments to reconcile net loss to net cash used in operating activities:
Unrealized loss on foreign currency transactions
Depreciation and amortization
Allowance for credit losses
Impairment for long-lived assets
Impairment for equity-method investment
Inventory reserve
Loss (gain) on disposal of equipment
Share of loss from an equity method investee
Share-based compensation
Accrued interest
Change in fair value of warrant liability
Change in fair value of convertible note receivable
Non-cash operating lease expenses
Derecognition of right-of-use asset and lease liability

Changes in operating assets and liabilities:
Accounts receivable
Contract assets
Amounts due from related parties
Inventories
Prepayments and other current and non-current assets
Accounts payable
Deferred revenue
Accrued liabilities and other current liabilities
Customer deposits
Deferred government grants
Operating lease liabilities
Other non-current liabilities
Net cash used in operating activities
Cash flows from investing activities:
Proceeds from maturity of short-term investments
Proceeds from disposal of equipment
Prepayment for property and equipment, and intangible assets
Purchase of property and equipment
Purchase of intangible assets
Purchase of long-term investment
Purchase of convertible note
Purchase of short-term investments
Net cash used in investing activities

Cash flows from financing activities:
Financing lease obligation payments
Proceeds received from capital injection
Proceeds from issuance of convertible preferred shares and warrant
Proceeds from issuance of Class A ordinary shares in connection with Employee Share Incentive Plans
Capital lease obligation payments
Refund of consideration for Employee Share Incentive Program
Repurchase of ordinary shares
Repayment of short-term borrowings
Purchase of treasury stock
Repurchase of convertible preferred shares
Proceeds from long-term borrowings
Proceeds from short-term borrowings
Proceeds from IPO and concurrent private placement ("CPP"), net of issuance costs
Repayment of long-term borrowings
Net cash (used in)/generated from financing activities

Effect of exchange rate on cash, cash equivalents and restricted cash
Net decreases in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at the beginning of year
Cash, cash equivalents and restricted cash at the end of year
Supplemental disclosures of cash flow information:
Interest expense paid
Cash payments for operating lease
Income tax expense paid

Supplemental disclosures of non-cash information:
Purchase of property and equipment included in prepayments and other non-current assets
Purchase of property and equipment included in accounts payable
Purchase of property and equipment included in capital lease obligations
Extinguishment of warranty liability through exercise of warrant
Conversion of convertible notes into Series C convertible preferred shares
Derecognition of right-of-use asset and lease liability

Reconciliation of cash, cash equivalents and restricted cash:
Cash and cash equivalents
Restricted cash

Comments